VC fund (Cat II) · Curated list
ChrysCapital
Growth (Series C+) · IT / SaaS / Enterprise Software · Mumbai
At a glance
- Stage focus
- Growth (Series C+)
- Primary sector
- IT / SaaS / Enterprise Software
- City
- Mumbai
- HQ / office
- India operating HQ (per multiple third-party sources): 502 Ceejay House, Dr. Annie Besant Road, Worli, Mumbai 400034, India. The official Contact page (chryscapital.com/contact-us) lists ONLY two Mauritius fund-domicile offices: Suite 604, St. James Court, Port Louis 11328, Mauritius (Tel +230 211 5410); and Apex House, Bank Street, TwentyEight, Cybercity, Ebene 72201, Mauritius (Tel +230 467 3000). The Mumbai address is corroborated by third parties only and is NOT stated on the official contact page.
- Fund registered
- 2024
- Investments on record
- 100
- Corpus (as reported)
- ~$5 billion raised across nine PE funds since inception (per official site); closed its 10th fund (Fund X) at a record $2.2 billion in November 2025 — India's largest-ever PE fund (confirmed by Cooley and Bloomberg). Some reports cite ~$10bn raised cumulatively across all vintages.
- Website
- chryscapital.com
- Profile ↗
About
ChrysCapital is one of India's largest and most established India-focused private equity firms, founded in 1999 by Ashish Dhawan (who stepped back in 2011 for philanthropy). It is led today by Managing Partner Kunal Shroff (with the firm since 1999) and senior partners including Ashley Menezes and Sanjay Kukreja. The firm makes growth and control/buyout investments across consumer, financial services, healthcare/pharma, technology, manufacturing and new economy, and operates a value-creation function. In November 2025 it closed Fund X at a record $2.2 billion.
Investment focus
Growth/late-stage private equity, control and buyout investments (NOT early-stage VC); exit-oriented, big-ticket cheques into established companies. Sectors per official site: Consumer, Enterprise Technology, Financial Services, Healthcare, Manufacturing, New Economy.
Cheque size
Growth/control PE; large cheques (firm has invested ~USD 4.5bn across 100+ deals; typical equity investments in the tens to low-hundreds of USD millions). No precise official ticket range disclosed.
As compiled from public sources — verify with the investor.
SEBI registration
SEBI AIF Category II — reported as “Major/growth VC / Cat II”
- IN/AIF2/24-25/1524
SIDBI Fund of Funds
None found — ChrysCapital is a large established growth/buyout PE firm (USD ~5bn AUM across 9 funds); no evidence of SIDBI FFS or other government/DFI LP relationship. FFS targets startup-stage AIFs, not a fund of this scale.
Notable portfolio
Intas Pharmaceuticals; Mankind Pharma; Torrent Pharma; AU Small Finance Bank; Shriram Finance; Mahindra Finance; LTIMindtree; Infogain
Team & organisation
~77 people including ~22 partners (per Tracxn); founded 1999.
India-focused growth/control private equity manager; multi-fund (ChrysCapital I–IX), with India advisory entity (ChrysCapital Investment Advisors India Pvt Ltd) and Mauritius-domiciled fund vehicles. SEBI Category II AIF / offshore fund structure.
Connect through iHub India
Open a funding round and send a structured pitch from this profile. It's recorded now and delivered the moment this investor joins iHub India; if they accept, contact details are shared and the conversation moves into a tracked deal room.
Raising a round? Send a funding pitch with your traction — an acceptance opens a tracked deal room. Mentors, incubators, corporates and students can request an intro instead.
Work at ChrysCapital? Claim this profile to keep it current and receive pitches directly.
Frequently asked
- What does ChrysCapital invest in?
- Growth/late-stage private equity, control and buyout investments (NOT early-stage VC); exit-oriented, big-ticket cheques into established companies. Sectors per official site: Consumer, Enterprise Technology, Financial Services, Healthcare, Manufacturing, New Economy.
- What cheque size does ChrysCapital write?
- As compiled from public sources: Growth/control PE; large cheques (firm has invested ~USD 4.5bn across 100+ deals; typical equity investments in the tens to low-hundreds of USD millions). No precise official ticket range disclosed.
- How do I pitch ChrysCapital through iHub India?
- Create a free startup account, open a funding round, and send a structured pitch from this profile. If the investor accepts, contact details are shared and the conversation moves into a tracked deal room.
Similar investors
VC fund (Cat II)
021 Capital Trust
Seed · IT / SaaS / Enterprise Software · Bengaluru
VC / investor (non-AIF or offshore)
100X.VC
Pre-seed / Idea · IT / SaaS / Enterprise Software · Mumbai
VC fund (Cat II)
108 Capital Venture Fund
Growth (Series C+) · Not disclosed · Bengaluru
VC fund (Cat I)
35North India Growth Fund Trust
Growth (Series C+) · Fintech · Mumbai
VC fund (Cat II)
3one4 Capital
Multi-stage · IT / SaaS / Enterprise Software · Bengaluru
VC fund (Cat I)
3ONE4CAPITAL TRUST
Seed · IT / SaaS / Enterprise Software · Bengaluru
About this record
- ⚑ NOT an early-stage VC — ChrysCapital is a large-cap growth-equity / buyout PE firm writing big-ticket cheques into established companies; likely a poor fit for a startup-acceleration / EDC program targeting growth-stage early startups. Fund vehicles are domiciled in Mauritius (offshore); India operating office is in Mumbai (not published on the official contact page). The official site publishes ONLY [contact on file] plus a contact form — there is NO deal-flow/IR/pitch email; the careers inbox is for recruiting and must NOT be used for investment outreach. A separate look-alike domain 'chryscapitalllp.com' surfaced in search — treat as unrelated/unverified; the genuine domain is chryscapital.com.
Compiled from SEBI registrations and public sources as of 2026-07. iHub India lists investors neutrally and does not endorse, rank, or verify investment terms — confirm all details directly with the investor before transacting.
Sources: https://chryscapital.com/contact-us/; https://chryscapital.com/about-us/